DxD Hub and Giromed Partner to Revolutionize Data Management in Clinical Trials with a New Digital Platform
Together, they have developed an innovative platform that optimizes the management and traceability of data in clinical trials. This solution digitalizes and streamlines the data acquisition process, ensuring greater efficiency, accuracy, and security at every stage of the study.
This new platform addresses a critical challenge in clinical trials: the management of data from various sources, a labor-intensive and error-prone process. By reading the clinical trial protocol and generating a comprehensive agenda for patients, the platform digitalizes all data, including tests such as blood analysis, biomarkers, EKGs, lung function tests, and clinical staff notes during visits. This ensures data traceability and harmonization, significantly improving data quality and reducing manual effort, which saves time.
Luiz Correa, General Manager of DxD, emphasizes the role of digital transformation in healthcare: “The digitalization of data in clinical trials is essential to modernize healthcare operations. Our new solution not only saves time for clinicians and researchers but also creates an environment with interoperable tools that stakeholders can adapt to their specific needs. It is a transformative approach to ensuring accuracy, traceability, and efficiency in clinical research.”
This initiative is part of DxD Hub and Giromed’s commitment to improving healthcare processes with innovative digital solutions. The clinical trials platform is fully compatible with the DxD environment, making it an ideal option for hospitals, laboratories, and research groups in areas such as lung and breast cancer.
Juan Escayola, CIO of DxD, with his 20 years of experience in data management in the pharmaceutical and healthcare industry, states: “This platform represents a significant advancement in data integration and interoperability. With this tool, we are setting a new standard of quality and efficiency in clinical trial data, facilitating decision-making for healthcare professionals.”
The need for these advancements comes at a crucial time, as Spain consolidates its position as a leader among European countries in conducting clinical trials. According to industry information, Spain’s infrastructure and experience in clinical research make these types of proposals an excellent opportunity for clinical research centers to optimize their operations and improve data management in clinical trials.
Juan Roldán, CEO of Giromed, highlights: “Document management in clinical trials is a complex and demanding process. Our innovative solution, developed in collaboration with DxD Hub, will enable remote monitoring with all guarantees of data security and traceability. This digital platform optimizes the management of visits and adverse events, reduces paper use, and ensures the quality, traceability, and integrity of the collected data.” With over 20 years of experience, Giromed drives the digitalization of clinical research.
This partnership underscores the ongoing commitment of DxD Hub and Giromed to innovation in healthcare and the advancement of precision medicine by addressing the main operational challenges in clinical trials.
The tool will soon be available for early access, allowing hospitals and research centers across Europe to enhance the efficiency of clinical trials and optimize patient outcomes. For more information about the tool and how to participate in the early access program, please contact DxD Hub.
About DxD Hub
DxD Hub is a consulting company in precision medicine that offers digital solutions to help laboratories, hospitals, and healthcare professionals improve data traceability, quality, and operational efficiency.
About Giromed
Giromed is a benchmark in personalized medicine in Spain, with a distinguished track record in applied clinical and basic research. Its close collaboration with national and international research groups drives the development of innovative studies, consolidating its leadership in the sector. This network of cooperation strengthens its commitment to scientific excellence and the progress of precision medicine.
